Sign-up for the third webinar in a 6-part series, titled, “Addressing the High Cost of Radiology Services.”

T​his webinar will highlight how community cancer programs are using a new approach to optimize biomarker testing processes through the addition of a precision medicine steward.

A webinar featuring Dr. Randall Oyer, Dr. Lori Pierce, Sanford Jeames, and Leila Hamroun, discussing the ASCO-ACCC joint collaboration, dissemination of the site self assessment and training program.

Sign-up for the second in a 6-part series, titled, “Proactive Interventions for the Prior Authorization Process”

Raise awareness among cancer programs of new treatment options for newly diagnosed patients with multiple myeloma ineligible for transplant.

Oncology state society leaders from the Appalachian Community Cancer Alliance share an introduction to the Alliance, their insights into the unique needs of the Appalachian region and beyond, how the Alliance is responding and how you can get involved.

This educational initiative will focus on multidisciplinary education surrounding TILs, with an emphasis on the importance of implementing clinical trials in the community setting.

The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.

This webinar will provide the foundational elements related to electronic patient-reported outcomes and remote patient monitoring for oncology practices and programs that are preparing to implement—or sustain—value-based care payment models.

A series of interactive modules outline key concepts such as diversity, equity, and health disparities, as well as the role of implicit bias in clinical trial selection. Vignettes provide real-world examples of implicit bias and guidance for mitigating disparities in cancer research settings.